TechCrunch  Mar 30  Comment 
 In an announcement met by hoots and hollers from the developers at Build, Microsoft introduced the ‘Centennial’ desktop app converter. With this, developers can convert their Win32 and .NET apps into the AppX app format for use in the...
Benzinga  May 30  Comment 
In a report published Friday, Deutsche Bank analyst Vijay Bhagavath downgraded the rating on Infoblox (NYSE: BLOX) from Buy to Hold, and lowered the price target from $30.00 to $18.00. In the report, Deutsche Bank noted, “BLOX reported Q3...
Benzinga  May 20  Comment 
In a report published Tuesday, Deutsche Bank analyst Greg Poole reiterated a Hold rating on NeoPhotonics (NYSE: NPTN), but lowered the price target from $5.50 to $4.50. In the report, Deutsche Bank noted, “Maintain Hold on weak (low 20s)...
Benzinga  Jan 23  Comment 
The Medicines Company (NASDAQ: MDCO) today announced that it has settled the lawsuits filed by MDCO in the U.S. District Court for the District of Delaware relating to the Abbreviated New Drug Application filed by APP Pharmaceuticals, LLC for a...
TechCrunch  Nov 30  Comment 
W3i, a monetization and distribution network for mobile app developers, is announcing the launch of a new $10 million "AppX Game Developer Marketing Fund" at this week's AppNation conference in San Francisco. The fund will provide developers with...
MedPage Today  Mar 28  Comment 
(MedPage Today) -- APP Pharmaceuticals has recalled five lots of irinotecan hydrochloride, used to treat metastatic colorectal cancer, because fungal contamination was found in one lot.
StreetInsider.com  Oct 8  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/APP+Pharmaceuticals+%28APCVZ%29+Receives+OK+from+FDA+to+Market+Sumatriptan+Succinate+Injection/5004564.html for the full story.




 


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki